Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Is there a consensus on using NSAIDs for acute gout?

I read with interest your learning article on gout (The Pharmaceutical Journal, 2014;293:182). However, I am rather confused over the reference to using non-steroidal anti-inflammatory drugs (NSAIDs) in the treatment of acute gout. I was always under the impression that ibuprofen should not be used in the treatment of acute gout but in the article the author says there is no convincing evidence that any NSAID is better than another.

A quick look at the British National Formulary (BNF) found: “Ibuprofen is a propionic acid derivative with anti-inflammatory, analgesic, and antipyretic properties. It has fewer side effects than other non-selective NSAIDs but its anti-inflammatory properties are weaker. Doses of 1.6g to 2.4g daily are needed for rheumatoid arthritis and it is unsuitable for conditions where inflammation is prominent, such as acute gout.”

So does this mean the BNF is wrong and this should be removed, or is it just the author’s opinion that there is no difference between different NSAIDs in the treatment of acute gout? When I looked online it appears many websites do suggest that ibuprofen can be used for acute gout, but NHS Choices agrees with BNF advice.

Michael Franks

Highgate

 

Tina Hawkins, author of “Acute management and treatment of gout”, responds: In the article I was referring to the specific NSAIDs licensed for acute gout and where trials have been performed. I was involved in producing the statement in the BNF that ibuprofen is not recommended in acute gout and, to clarify, in those NSAIDs licensed for the acute management of gout there is no convincing evidence that one of these agents should be used in preference to another. Sorry for any confusion caused.

Citation: The Pharmaceutical Journal URI: 20066356

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Biological Therapeutics

    Biological Therapeutics

    An introduction to the treatment of disease using biological medicines derived from living plant and animal tissues.

    £33.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.